Featured Research

from universities, journals, and other organizations

New Procedure For Uterine Preservation In Treating Fibroids

Date:
December 6, 2006
Source:
Thomas Jefferson University
Summary:
Although fibroids can cause pelvic pain, abnormal vaginal bleeding and infertility, women of childbearing age often choose to forego treatment because the options don't guarantee fertility. In the December issue of The Female Patient, physicians at Thomas Jefferson University Hospital in Philadelphia present a case history of a 35-year-old woman whose numerous fibroids formed a large mass in her pelvic area that, when initially diagnosed, was of a size comparable to a full-term pregnancy.

Although fibroids--benign tumors that grow in the uterus--can cause pelvic pain, abnormal vaginal bleeding and infertility, women of childbearing age often choose to forego treatment because the available treatment options don't guarantee fertility.

In a study in the December issue of The Female Patient, physicians at Thomas Jefferson University Hospital in Philadelphia present a case history of a 35-year-old women whose numerous fibroids formed a large mass in her pelvic area that, when initially diagnosed, was of a size comparable to a full-term pregnancy.

"Traditionally, treatment for such a large fibroid mass in the uterus has been limited to hysterectomy, because the patient would bleed extensively if an attempt was made to merely remove the fibroids." says Jay Goldberg, M.D., MSCP, lead author and director of the Jefferson Fibroid Center at Thomas Jefferson University. "In this particular case though, hysterectomy was not an option because the patient strongly desired future fertility and uterine preservation."

To meet the patient's wishes and remove the fibroids, the physicians developed a plan to perform two procedures a month apart.

The Jefferson physicians first performed a uterine fibroid embolization (UFE), a minimally invasive radiologic procedure that blocks the arteries that supply blood to the fibroid tumors. The procedure was done to reduce the blood flow within the patient's uterus and the risk of hemorrhaging at the time of surgery.

One month later, the patient underwent an abdominal myomectomy. In this procedure, the fibroids are removed through an abdominal skin incision. After the UFE, her initially 38-week sized uterus had decreased to a 34-week size, with decreased blood flow. Eleven large fibroids were removed during the myomectomy, with minimal blood loss. The patient was discharged from the hospital on the second day post-surgery and experienced no complications.

Dr. Goldberg, who is also director, Division of General Obstetrics at Thomas Jefferson University, and his colleagues recommend the combination of procedures for women who want to preserve their uterus. "We are noting a trend toward more women requesting uterine-preserving treatment for fibroids--even with massively enlarged uteri, and even when future fertility may not be a consideration," they write.


Story Source:

The above story is based on materials provided by Thomas Jefferson University. Note: Materials may be edited for content and length.


Cite This Page:

Thomas Jefferson University. "New Procedure For Uterine Preservation In Treating Fibroids." ScienceDaily. ScienceDaily, 6 December 2006. <www.sciencedaily.com/releases/2006/12/061205080953.htm>.
Thomas Jefferson University. (2006, December 6). New Procedure For Uterine Preservation In Treating Fibroids. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2006/12/061205080953.htm
Thomas Jefferson University. "New Procedure For Uterine Preservation In Treating Fibroids." ScienceDaily. www.sciencedaily.com/releases/2006/12/061205080953.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins